70 likes | 172 Views
Trial profile. GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]. Baseline characteristics of patients. GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print].
E N D
Trial profile GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]
Baseline characteristics of patients GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]
Kaplan-Meier curves for time to all-cause death (A) and for time to all-cause death or admission to hospital for cardiovascular reasons (B) GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]
Secondary outcomes GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]
Causes of death GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]
Predefined subgroup analysis-composite endpoint of all-cause death or admission to hospital for cardiovascular reasons GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]
Permanent treatment discontinuations and adverse drug reactions GISSI-HF investigators. Lancet 2008; Aug 29 [Epub ahead of print]